Text Size
965 studies found for:    Open Studies | "Lung Diseases, Obstructive"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Conditions: Diabetic Type 1 With Obstructive Pulmonary Disease;   Diabetic Type 2 With Obstructive Pulmonary Disease;   Asthma;   COPD;   Type 1 Diabetes;   Type 2 Diabetes;   Indeterminate Obstructive Lung Disease
Interventions: Drug: Technosphere Insulin;   Drug: Usual Care
2 Recruiting Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Conditions: Lung Diseases, Obstructive;   Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Device: Yamax Digi-Walker CW-700
3 Recruiting Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Conditions: COPD;   COPD Exacerbation;   Lung Diseases;   Respiratory Disorders;   Pulmonary Disease;   Chronic Obstructive Lung Diseases;   Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
4 Not yet recruiting Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Moderate Chronic Obstructive Pulmonary Disease;   Severe Chronic Obstructive Pulmonary Disease;   Dyspnea
Intervention: Drug: Combination ipratropium/salbutamol or placebo (nebulization)
5 Recruiting Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Pulmonary Emphysema;   Bronchitis, Chronic;   Lung Diseases;   Disease Progression
Intervention:
6 Unknown † Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
7 Unknown † T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
8 Unknown † Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Intervention:
9 Not yet recruiting The Canadian Cohort Obstructive Lung Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Intervention:
10 Unknown † Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
11 Not yet recruiting Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
12 Recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
13 Recruiting Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
14 Recruiting Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
15 Not yet recruiting Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: glycopyrronium bromide
16 Unknown † Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
17 Recruiting Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: NVA237 50µg once daily;   Drug: Tiotropium 18µg once daily;   Drug: Placebo;   Drug: NVA237 placebo + Tiotropium placebo.
18 Recruiting Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE;   ASTHMA;   HEALTHY SUBJECTS
Intervention: Drug: SALBUTAMOL
19 Recruiting Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   COPD Exacerbation;   Smoking
Interventions: Drug: Varenicline;   Drug: placebo
20 Unknown † Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Ground Walking Program
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years